841.30 -1.25 (-0.15%)

New 52W High today

2.4M NSE+BSE Volume

NSEOct 14, 2021 03:31 PM



GET EVENTS ALERTS
New and upcoming Corporate actions, results and board meetings alerts are delivered to your inbox daily in the evening.

Board Meetings - Sun Pharmaceutical Industries Ltd.

See past and forthcoming board meetings of Sun Pharmaceutical Industries Ltd. - SUNPHARMA, 524715

Ex-datePurposeNotes
2021-11-02Quarterly Results
2021-07-30Quarterly Results
2021-05-27Audited Results & Final Dividend
2021-01-29Quarterly Results
2020-11-03Quarterly Results
2020-07-31Quarterly Results
2020-05-27Audited Results & Final Dividend
2020-03-17Buy Back of Shares
2020-02-06Quarterly Results
2019-11-07Quarterly Results
2019-08-13Quarterly Results
2019-05-28Audited Results & Dividend
2019-02-12Quarterly Results
2018-11-13Quarterly Results
2018-08-14Quarterly Results
2018-05-25Audited Results & Dividend
2018-02-14Quarterly Results
2017-11-14Quarterly Results
2017-05-26Audited Results & Dividend
2017-02-14Quarterly Results
2016-11-10Quarterly Results & OthersTo consider the proposal for the merger/amalgamation of Ranbaxy Drugs Limited, Vidyut Investments Limited, Gufic Pharma Limited and Sun Pharma Medisales Private Limited.
2016-08-12Quarterly Results
2016-06-23Buy Back of Equity Shares
2016-05-30Audited Results & Dividend
2016-02-12Quarterly Results
2015-11-07Quarterly Results
2015-08-11Quarterly Results & DividendConsideration of the revised audited annual accounts of the Co for the year ended 31/03/ 2015 after giving the effect to the Scheme of Amalgamation of SPGI into SPIL.
2015-05-29Audited Results & Amalgamation
2015-02-14Quarterly Results
2014-11-13Quarterly Results
2014-08-12Revised Audited, Qtr Results & DividendConsider the revised audited annual accounts of the Co. for the year ended March 31, 2014 after giving the effect to the Scheme of Arrangement and Reconstruction between between SPIL and SPGFZE.
2014-05-29Audited Results
2014-02-13Quarterly Results
2013-11-13Quarterly Results
2013-08-09Quarterly Results
2013-05-28Others
2013-02-08Quarterly Results
2012-11-08Quarterly Results
2012-08-10Interim dividend & OthersTo consider the internal restructuring of the business of the Company with effect from March 31,2012 & to consider declaration of the interim dividend of Rs.4.25 per Share of Re.1 each.
2012-05-29Audited Results & Dividend
2012-02-13Quarterly Results
2011-11-13Quarterly Results
2011-07-28Quarterly Results
2011-05-28Audited Results & Dividend
2011-01-31Quarterly Results
2010-10-30Quarterly Results
2010-09-24Stock splitThe Board has approved the proposal to sub-divide the nominal value of the Equity Shares of the Company from the nominal value of Rs. 5 each to the nominal value of Re. 1 each.
2010-07-28Quarterly Results
2010-05-24Audited Results & Dividend
2010-01-29Quarterly Results
2009-10-28Quarterly Results
2009-07-29Quarterly Results
2009-05-30Audited Results & Dividend
2009-01-30Quarterly Results
2008-10-25Quarterly Results
2008-07-28Quarterly Results
2008-05-30Audited Results & Dividend
2008-01-30Quarterly Results
2007-10-25Quarterly Results & OthersTo consider payment of interim dividend @ 6% p.a. on outstanding 1,37,40,030 Preference Shares of Re 1/- each on prorata basis for the period from April 01, 2007 to November 01, 2007.
2007-07-23Quarterly Results
2007-05-18Audited Results(Revised)
2007-03-10Interim Dividend
2007-01-29Quarterly Results
2006-10-19Quarterly Results
2006-07-26Quarterly Results
2006-06-06Accounts & DividendRecommendation of payment of preference share dividend @ 6% p.a. on outstanding Preference Shares for the year ended March 31, 2006.
2006-02-09Demergerinter alia, to consider the proposal for demerger of the Company's Innovative Research & Development (including new drug delivery systems) undertaking to a new company.
2006-01-30Quarterly Results
2005-10-28Quarterly Results
2005-08-18Accounts & Dividend
2005-07-27Quarterly Results
2005-04-27Quarterly Results
2005-04-04Acquisition of pharmaceutical businessDecided to acquire pharmaceutical business of M J Pharmaceuticals Ltd including its manufacturing unit at Halol, Gujarat along with all its assets and liabilities pertaining to pharmaceutical business
2005-02-08Merger/AmalgamationTo consider the proposal for merger / amalgamation of its wholly owned subsidiary companies (1) Bazley Finvest Pvt Ltd, (2) Dhaval Finvest Pvt Ltd and (3) Manish Finvest Pvt Ltd, with the Company.
2005-01-21Quarterly Results
2004-11-26Interim Dividend & OthersIssued US$ 275,000,000 Zero Coupon Foreign Currency Convertible Bonds (FCCB) due 2009 (subject to an increase of up to a further US$ 75,000,000 pursuant to the Option).
2004-10-21Quarterly Results
2004-07-31Quarterly Results
2004-04-21Dividend
2004-04-08OthersTo consider the issue of convertible debentures/bonds/securities through global depository receipts.
2004-01-28Quarterly Results
2003-10-21Quarterly Results(Revised)
2003-09-30OthersTo consider early closure of Buy Back programme of the Company through the Stock Exchange route before its normal validity period.
2003-07-28Quarterly Results
2003-05-03Dividend & Accounts
2003-01-30Quarterly Results
2002-12-20OthersFix record date for stock split of shares.
2002-10-28Stock Split, Quarterly Results & Othersfrom Rs.10/- each to Rs.5/- & & Buy Back of Shares
2002-07-22Quarterly Results
2002-06-28OthersTo issue of Bonus Preference Shares to the equity shareholders
2002-05-30Accounts, Dividend & OthersTo take on record BIFR order regarding merger of M.J.Pharmaceuticals Ltd. after its restructuring and to fix record date for merger & Dividend & Accounts
2002-04-26Quarterly Results
2002-03-21Interim Dividend(Cancelled)
2002-02-15AccountsTo approve the annual accounts incorporationg PDCL merger for the year ended 31/03/2001.
2002-01-22Quarterly Results
2001-11-28OthersInterim dividend on Redeemable Cumulative Non-convertible Preference Shares issued by the Company.
2001-10-19Quarterly Results
2001-07-30Interim Dividend & Quarterly Results
2001-04-19Quarterly Results
2001-03-22MergerMerger/Amalgamation of Sun Pharmaceutical Advanced Research Centre Ltd. with the Company, Interim Dividend on preference shares and Forfeiture of 500 partly paid equity shares